Compare CBRL & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBRL | PRME |
|---|---|---|
| Founded | 1969 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 694.2M | 666.1M |
| IPO Year | 1998 | 2022 |
| Metric | CBRL | PRME |
|---|---|---|
| Price | $27.57 | $3.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $37.75 | $6.42 |
| AVG Volume (30 Days) | 1.1M | ★ 2.5M |
| Earning Date | 06-04-2026 | 06-01-2026 |
| Dividend Yield | ★ 3.59% | N/A |
| EPS Growth | 12.57 | ★ 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,030,445,000.00 | $4,632,000.00 |
| Revenue This Year | N/A | $15.20 |
| Revenue Next Year | $3.62 | $316.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 3.56 | ★ 55.28 |
| 52 Week Low | $24.85 | $1.11 |
| 52 Week High | $68.09 | $6.94 |
| Indicator | CBRL | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 34.50 | 46.17 |
| Support Level | $25.24 | $3.19 |
| Resistance Level | $29.73 | $4.66 |
| Average True Range (ATR) | 1.73 | 0.32 |
| MACD | -0.55 | -0.02 |
| Stochastic Oscillator | 3.98 | 34.71 |
Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. The Cracker Barrel stores consists of a restaurant with a gift shop. The restaurants serve breakfast, lunch and dinner. The gift shop offers a variety of decorative and functional items specializing in rocking chairs, holiday gifts, toys, apparel and foods.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.